Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Canadian Journal of Physiology and Pharmacology|April 8, 2024
Discontinuing semaglutide after weight loss: strategy for weight maintenance and a possible new side effectNicholas W Carris, Shawn Wallace, Christopher G DuCoin, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 5, 2023
A Systematic Approach to Treating Early Metabolic Disease and PrediabetesNicholas W Carris, Brian E Bunnell, Rahul Mhaskar, et al.
International Journal of Obesity (2005)|March 29, 2025
Automated lifestyle interventions and weight loss: a systematic review of randomized controlled trialsNicholas W Carris, Krystal Bullers, Mariam McKee, et al.
Expert Opinion on Pharmacotherapy|September 23, 2020
Evaluation of cardiovascular and renal outcomes with ertugliflozin: what is the VERdict from the VERTIS-CV trial?Kevin Cowart, Nicholas W Carris
Current Hypertension Reports|June 28, 2015
Quality of Life in Treatment-Resistant HypertensionNicholas W Carris, Steven M Smith
The Annals of Pharmacotherapy|August 12, 2023
A Review of the Safety and Efficacy of Bexagliflozin for the Management of Type 2 DiabetesKevin Cowart, Scott Coon, Nicholas W Carris
Journal of Medical Ethics|July 26, 2020
Open data, trials and new ethics of using others' workNicholas W Carris, Byron Cheon, Jay Wolfson
Journal of the American Pharmacists Association : Japha|August 16, 2017
The changing cost to prevent diabetes: A retrospective analysis of the Diabetes Prevention ProgramNicholas W Carris, Feng Cheng, William N Kelly
Pageof 12